NMRA vs WTW · $283.5M cap vs P/E 15, rev $9.93B
Neumora Therapeutics, Inc. (NMRA) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
NMRA does not have a complete income-statement cache yet.
Latest reported WTW revenue for 2024-12-31 was $9.93B. Net income was -$88.0M. Revenue was up 4.7% from 2023-12-31 to 2024-12-31. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
NMRA currently screens at market cap $283.5M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the NMRA and WTW stock pages for the full models.
Not investment advice.